Long-term safety of antihypertensive therapy

Keyphrases

• Antihypertensive Therapy 100%
• Long-term Safety 100%
• Hypertensive Patients 100%
• Antihypertensive Agents 100%
• Calcium Antagonists 75%
• Myocardial Infarction 75%
• Cardiovascular Mortality 75%
• Diabetic 50%
• Angiotensin Receptor Blockers 50%
• Cardiovascular Morbidity 50%
• Blood Pressure Lowering 50%
• Beta-blockers 25%
• Hypertension 25%
• Heart Rate 25%
• Blood Pressure 25%
• Young Age 25%
• Prospective Randomized Trial 25%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 25%
• Glucose Tolerance 25%
• Middle-aged 25%
• Non-diabetic 25%
• First-line Therapy 25%
• Cardiovascular Events 25%
• Short-acting 25%
• Hypertensive 25%
• Plethora 25%
• Matters of Concern 25%
• Diuretics 25%
• Pre-diabetes (pre-DM) 25%
• Thiazide Diuretics 25%
• Uncomplicated Hypertension 25%
• Potassium Sparing 25%
• Diabetes Mellitus 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Antihypertensive Agent 100%
• Diabetes Mellitus 100%
• Antihypertensive Therapy 100%
• Morbidity 75%
• Calcium Antagonist 75%
• Heart Infarction 75%
• Angiotensin Receptor Antagonist 50%
• Hypertension 50%
• Malignant Neoplasm 25%
• Dipeptidyl Carboxypeptidase Inhibitor 25%
• Beta Adrenergic Receptor Blocking Agent 25%
• Isotopes of Potassium 25%
• Thiazide Diuretic Agent 25%
• Cardiovascular Mortality 25%
• Diuretics 25%
• Glucose 25%
• Potassium 25%